| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |